Reduction of femoral arterial bleeding post catheterization using percutaneous application of fibrin sealant
US5814066A · kind A · utility
72Cited by
2References
6Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 23, 1994 |
| Grant date | Sep 29, 1998 |
| Priority date | — |
| Expiry date | Dec 23, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61B2017/00495
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
Post catheterization arterial bleeding is reduced by introduction of a fibrin sealant, prepared from fibrinogen and thrombin, into the periarterial tissue surround the arteriotomy through which the catheter was inserted. The fibrin sealant is introduced as the catheter is withdrawn, which introduction may be accompanied by local pressure. The fibrin sealant, prepared from fibrinogen and thrombin, clots or "sets" to form a fibrin seal, reducing arterial bleeding and post catheterization difficulties.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.